|
SONN Sonnet Biotherapeutics Holdings Inc 1106838 |
| Income Statement |
|
Revenue
|
form10-q
|
1,000,000 |
|
Net Income
|
form10-q
|
-3,160,706 |
|
Profit Margin
|
|
-316.07% |
| Balance Sheet |
|
Current Assets
|
6,725,163 |
|
Assets
|
7,182,027 |
|
Current Liabilities
|
3,121,824 |
|
Liabilities
|
3,145,458 |
|
Equity
|
4,036,569 |
|
Shares Out
|
5,203,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,910,246 |
|
Investing Cash Flow
|
-12,000 |
| Market Analysis |
Market Cap
|
4,984,993 |
|
Price
|
1.39 |
|
BVPS
|
0.78 |
|
PB
|
1.78 |
|
EPS
|
-3.02 |
|
PS
|
1.25 |
|
FCF
|
-2,922,246 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SONN documents filed with the SEC.
SONN Filings
Clear
